Gideon Capital Advisors’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-3,856
Closed -$236K 478
2018
Q4
$236K Sell
3,856
-1,278
-25% -$86.2K 0.1% 322
2018
Q3
$423K Sell
5,134
-3,365
-40% -$267K 0.2% 177
2018
Q2
$665K Sell
8,499
-712
-8% -$55.2K 0.33% 85
2018
Q1
$679K Buy
9,211
+4,123
+81% +$293K 0.42% 63
2017
Q4
$347K Sell
5,088
-3,054
-38% -$198K 0.31% 114
2017
Q3
$501K Buy
8,142
+1,675
+26% +$103K 0.49% 48
2017
Q2
$406K Buy
6,467
+851
+15% +$48.5K 0.45% 79
2017
Q1
$312K Sell
5,616
-2,352
-30% -$121K 0.19% 241
2016
Q4
$381K Buy
+7,968
New +$446K 0.24% 161

Other funds holding NUS

Gideon Capital Advisors's NUS Position: Q1 2019 in Review

Gideon Capital Advisors sold out of Nu Skin (NUS) in Q1 2019, closing a stake of 3,856 shares — an estimated $236K sold.

Gideon Capital Advisors first reported a position in NUS in Q4 2016 and held it in 9 quarters. The position peaked at $679K in Q1 2018. 277 funds tracked by Wall St. Rank hold NUS as of Q1 2019.

  • Gideon Capital Advisors reported no remaining Nu Skin position as of Q1 2019 after selling out during the quarter.
  • Gideon Capital Advisors sold 3,856 Nu Skin shares in Q1 2019, an estimated $236K.
  • Gideon Capital Advisors first reported a position in Nu Skin in Q4 2016 and held it in 9 quarters.
  • Gideon Capital Advisors's Nu Skin position peaked at $679K in Q1 2018.
  • 277 funds tracked by Wall St. Rank held Nu Skin as of Q1 2019.

Based on Gideon Capital Advisors's 13F filing for Q1 2019, filed 14 May 2019.